New inhibitors of dopamine beta-hydroxylase.
D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003485:Cyanates / Q000494:pharmacology*; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007211:Indoles / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D008353:Mannitol / Q000031:analogs & derivatives* / Q000494:pharmacology; D008713:Methimazole / Q000031:analogs & derivatives* / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011247:Pregnancy; D011359:Proestrus; D051381:Rats
D003485:Cyanates; D007211:Indoles; D008353:Mannitol; D008713:Methimazole; D007986:Luteinizing Hormone; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine; D004837:Epinephrine